Showing results (71-80 of 139) with videos related to
Sort By:
Pageof 14
Taiwanese Journal of Obstetrics & Gynecology|March 2, 2016
Low-dose add-back therapy during postoperative GnRH agonist treatmentHsiao-Wen Tsai, Peng-Hui Wang, Ben-Shian Huang, et al.Biomed Research International|July 10, 2018
Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular DiseasesTao Yi, Jinxia Wang, Kaixi Zhu, et al.Pharmaceutical Statistics|April 17, 2012
Establishing consistency across all regions in a multi-regional clinical trialHsiao-Hui Tsou, H M James Hung, Yue-Ming Chen, et al.Foods (Basel, Switzerland)|December 23, 2022
Melatonin Treatment Affects Wax Composition and Maintains Storage Quality in 'Kongxin' Plum (Prunus salicina L. cv) during PostharvestXin Lin, Shian Huang, Donald J Huber, et al.Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|January 22, 2016
[Pathologic markers for evaluation of reversibility in pulmonary hypertension related to congenital heart disease]Li Li, Li Huang, Guo Chen, et al.Taiwanese Journal of Obstetrics & Gynecology|December 17, 2014
Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementationKuan-Hao Tsui, Li-Te Lin, Huann-Cheng Horng, et al.Biomed Research International|April 22, 2017
Quercetin Inhibits Pulmonary Arterial Endothelial Cell Transdifferentiation Possibly by Akt and Erk1/2 PathwaysShian Huang, Xiulong Zhu, Wenjun Huang, et al.Pulmonary Circulation|November 15, 2019
Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF-κB signaling pathwaysGuosen Yan, Jinxia Wang, Tao Yi, et al.The Journal of Pharmacy and Pharmacology|September 27, 2015
Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptorYiqiang Xue, Xiaorong Shui, Weiqing Su, et al.Biomolecules|July 27, 2024
The Role of Hyperuricemia in Cardiac Diseases: Evidence, Controversies, and Therapeutic StrategiesYue Zheng, Zhirui Chen, Jinya Yang, et al.Pageof 14